View in EDS HTML Full Text PDF Full Text

BEST-MS: A prospective head-to-head comparative study of natalizumab and fingolimod in active relapsing MS.

Saved in:
Bibliographic Details
Title: BEST-MS: A prospective head-to-head comparative study of natalizumab and fingolimod in active relapsing MS.
Authors: Cohen M; Service de Neurologie, CRCSEP, Unité de Recherche Clinique Cote d'Azur (UR2CA), Centre Hospitalier Universitaire Pasteur 2, Nice, France., Mondot L; Service de Radiologie, Unité de Recherche Clinique Cote d'Azur (UR2CA), Centre Hospitalier Universitaire Pasteur 2, Nice, France., Bucciarelli F; Neurosciences Department, CRCSEP, University Hospital of Toulouse, Toulouse, France/INSERM U1043-CNRS UMR 5282, Centre de Physiopathologie Toulouse, Toulouse, France., Pignolet B; Neurosciences Department, CRCSEP, University Hospital of Toulouse, Toulouse, France/INSERM U1043-CNRS UMR 5282, Centre de Physiopathologie Toulouse, Toulouse, France., Laplaud DA; CRTI-INSERM U1064, CIC 1413, Service de Neurologie, CHU Nantes, Nantes, France., Wiertlewski S; CRTI-INSERM U1064, CIC 1413, Service de Neurologie, CHU Nantes, Nantes, France., Brochet B; Service de Neurologie, CRC SEP, Centre Hospitalier Universitaire (CHU) de Bordeaux, Bordeaux, France., Ruet A; Service de Neurologie, CRC SEP, Centre Hospitalier Universitaire (CHU) de Bordeaux, Bordeaux, France., Defer G; Service de Neurologie, CHU de Caen, Avenue de la Côte de Nacre, Caen, France., Derache N; Service de Neurologie, CHU de Caen, Avenue de la Côte de Nacre, Caen, France., Vermersch P; Univ. Lille, INSERM U1172, CHU Lille, FHU Imminent, Lille, France., Zephir H; Univ. Lille, INSERM U1172, CHU Lille, FHU Imminent, Lille, France., Debouverie M; CHRU-Nancy, INSERM, Université de Lorraine, CIC, Epidémiologie Clinique, Nancy, France., Mathey G; CHRU-Nancy, INSERM, Université de Lorraine, CIC, Epidémiologie Clinique, Nancy, France., Berger E; Service de Neurologie, CHU de Besançon, Besançon, France., Cappé C; Centre d'investigation clinique, CHU de Besançon, Besançon, France., Labauge P; CHU de Montpellier, MS Unit, Montpellier, France., Carra C; CHU de Montpellier, MS Unit, Montpellier, France., De Seze J; Clinical Investigation Center, Department of Neurology, CHU de Strasbourg, INSERM 1434, Strasbourg, France., Bigaut K; Clinical Investigation Center, Department of Neurology, CHU de Strasbourg, INSERM 1434, Strasbourg, France., Brassat D; Neurosciences Department, CRCSEP, University Hospital of Toulouse, Toulouse, France/INSERM U1043-CNRS UMR 5282, Centre de Physiopathologie Toulouse, Toulouse, France., Lebrun-Frenay C; Service de Neurologie, CRCSEP, Unité de Recherche Clinique Cote d'Azur (UR2CA), Centre Hospitalier Universitaire Pasteur 2, Nice, France.
Source: Multiple sclerosis (Houndmills, Basingstoke, England) [Mult Scler] 2021 Sep; Vol. 27 (10), pp. 1556-1563. Date of Electronic Publication: 2020 Oct 30.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: SAGE Publications Country of Publication: England NLM ID: 9509185 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1477-0970 (Electronic) Linking ISSN: 13524585 NLM ISO Abbreviation: Mult Scler Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 33124504
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: BEST-MS: A prospective head-to-head comparative study of natalizumab and fingolimod in active relapsing MS.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Cohen+M%22">Cohen M</searchLink>; Service de Neurologie, CRCSEP, Unité de Recherche Clinique Cote d'Azur (UR2CA), Centre Hospitalier Universitaire Pasteur 2, Nice, France.<br /><searchLink fieldCode="AU" term="%22Mondot+L%22">Mondot L</searchLink>; Service de Radiologie, Unité de Recherche Clinique Cote d'Azur (UR2CA), Centre Hospitalier Universitaire Pasteur 2, Nice, France.<br /><searchLink fieldCode="AU" term="%22Bucciarelli+F%22">Bucciarelli F</searchLink>; Neurosciences Department, CRCSEP, University Hospital of Toulouse, Toulouse, France/INSERM U1043-CNRS UMR 5282, Centre de Physiopathologie Toulouse, Toulouse, France.<br /><searchLink fieldCode="AU" term="%22Pignolet+B%22">Pignolet B</searchLink>; Neurosciences Department, CRCSEP, University Hospital of Toulouse, Toulouse, France/INSERM U1043-CNRS UMR 5282, Centre de Physiopathologie Toulouse, Toulouse, France.<br /><searchLink fieldCode="AU" term="%22Laplaud+DA%22">Laplaud DA</searchLink>; CRTI-INSERM U1064, CIC 1413, Service de Neurologie, CHU Nantes, Nantes, France.<br /><searchLink fieldCode="AU" term="%22Wiertlewski+S%22">Wiertlewski S</searchLink>; CRTI-INSERM U1064, CIC 1413, Service de Neurologie, CHU Nantes, Nantes, France.<br /><searchLink fieldCode="AU" term="%22Brochet+B%22">Brochet B</searchLink>; Service de Neurologie, CRC SEP, Centre Hospitalier Universitaire (CHU) de Bordeaux, Bordeaux, France.<br /><searchLink fieldCode="AU" term="%22Ruet+A%22">Ruet A</searchLink>; Service de Neurologie, CRC SEP, Centre Hospitalier Universitaire (CHU) de Bordeaux, Bordeaux, France.<br /><searchLink fieldCode="AU" term="%22Defer+G%22">Defer G</searchLink>; Service de Neurologie, CHU de Caen, Avenue de la Côte de Nacre, Caen, France.<br /><searchLink fieldCode="AU" term="%22Derache+N%22">Derache N</searchLink>; Service de Neurologie, CHU de Caen, Avenue de la Côte de Nacre, Caen, France.<br /><searchLink fieldCode="AU" term="%22Vermersch+P%22">Vermersch P</searchLink>; Univ. Lille, INSERM U1172, CHU Lille, FHU Imminent, Lille, France.<br /><searchLink fieldCode="AU" term="%22Zephir+H%22">Zephir H</searchLink>; Univ. Lille, INSERM U1172, CHU Lille, FHU Imminent, Lille, France.<br /><searchLink fieldCode="AU" term="%22Debouverie+M%22">Debouverie M</searchLink>; CHRU-Nancy, INSERM, Université de Lorraine, CIC, Epidémiologie Clinique, Nancy, France.<br /><searchLink fieldCode="AU" term="%22Mathey+G%22">Mathey G</searchLink>; CHRU-Nancy, INSERM, Université de Lorraine, CIC, Epidémiologie Clinique, Nancy, France.<br /><searchLink fieldCode="AU" term="%22Berger+E%22">Berger E</searchLink>; Service de Neurologie, CHU de Besançon, Besançon, France.<br /><searchLink fieldCode="AU" term="%22Cappé+C%22">Cappé C</searchLink>; Centre d'investigation clinique, CHU de Besançon, Besançon, France.<br /><searchLink fieldCode="AU" term="%22Labauge+P%22">Labauge P</searchLink>; CHU de Montpellier, MS Unit, Montpellier, France.<br /><searchLink fieldCode="AU" term="%22Carra+C%22">Carra C</searchLink>; CHU de Montpellier, MS Unit, Montpellier, France.<br /><searchLink fieldCode="AU" term="%22De+Seze+J%22">De Seze J</searchLink>; Clinical Investigation Center, Department of Neurology, CHU de Strasbourg, INSERM 1434, Strasbourg, France.<br /><searchLink fieldCode="AU" term="%22Bigaut+K%22">Bigaut K</searchLink>; Clinical Investigation Center, Department of Neurology, CHU de Strasbourg, INSERM 1434, Strasbourg, France.<br /><searchLink fieldCode="AU" term="%22Brassat+D%22">Brassat D</searchLink>; Neurosciences Department, CRCSEP, University Hospital of Toulouse, Toulouse, France/INSERM U1043-CNRS UMR 5282, Centre de Physiopathologie Toulouse, Toulouse, France.<br /><searchLink fieldCode="AU" term="%22Lebrun-Frenay+C%22">Lebrun-Frenay C</searchLink>; Service de Neurologie, CRCSEP, Unité de Recherche Clinique Cote d'Azur (UR2CA), Centre Hospitalier Universitaire Pasteur 2, Nice, France.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%229509185%22">Multiple sclerosis (Houndmills, Basingstoke, England)</searchLink> [Mult Scler] 2021 Sep; Vol. 27 (10), pp. 1556-1563. <i>Date of Electronic Publication: </i>2020 Oct 30.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22SAGE+Publications%22">SAGE Publications </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>9509185 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1477-0970 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2213524585%22">13524585 </searchLink><i>NLM ISO Abbreviation: </i>Mult Scler <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=33124504
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1177/1352458520969145
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1556
    Titles:
      – TitleFull: BEST-MS: A prospective head-to-head comparative study of natalizumab and fingolimod in active relapsing MS.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Cohen M
      – PersonEntity:
          Name:
            NameFull: Mondot L
      – PersonEntity:
          Name:
            NameFull: Bucciarelli F
      – PersonEntity:
          Name:
            NameFull: Pignolet B
      – PersonEntity:
          Name:
            NameFull: Laplaud DA
      – PersonEntity:
          Name:
            NameFull: Wiertlewski S
      – PersonEntity:
          Name:
            NameFull: Brochet B
      – PersonEntity:
          Name:
            NameFull: Ruet A
      – PersonEntity:
          Name:
            NameFull: Defer G
      – PersonEntity:
          Name:
            NameFull: Derache N
      – PersonEntity:
          Name:
            NameFull: Vermersch P
      – PersonEntity:
          Name:
            NameFull: Zephir H
      – PersonEntity:
          Name:
            NameFull: Debouverie M
      – PersonEntity:
          Name:
            NameFull: Mathey G
      – PersonEntity:
          Name:
            NameFull: Berger E
      – PersonEntity:
          Name:
            NameFull: Cappé C
      – PersonEntity:
          Name:
            NameFull: Labauge P
      – PersonEntity:
          Name:
            NameFull: Carra C
      – PersonEntity:
          Name:
            NameFull: De Seze J
      – PersonEntity:
          Name:
            NameFull: Bigaut K
      – PersonEntity:
          Name:
            NameFull: Brassat D
      – PersonEntity:
          Name:
            NameFull: Lebrun-Frenay C
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 09
              Text: 2021 Sep
              Type: published
              Y: 2021
          Identifiers:
            – Type: issn-electronic
              Value: 1477-0970
          Numbering:
            – Type: volume
              Value: 27
            – Type: issue
              Value: 10
          Titles:
            – TitleFull: Multiple sclerosis (Houndmills, Basingstoke, England)
              Type: main
ResultId 1